Efficacy of Therapeutic Exercise and Pain Neurophysiology Education in Temporomandibular Disorders

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorUniversity of Alcala

About this trial

The aim of this study is to compare the effects in pain of two different treatments in pacients with temporomandibular disorders (TMD). One group will receive isolated therapeutic exercise (TE) and the other will receive TE combined with pain neurophysiology education (PNE). The hypothesis of this study is that the PNE+TE group will obtain superior therapeutic results than an isolated TE program.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Over 18 years of age

Limitation of mouth opening and/or jaw pain lasting more than 6 months

Being able to understand the objective and carry out the study procedures

Sign the informed consent.

Disqualifiers

Suffer from any underlying disease

Pain due to tumors or infections, metastases, osteoporosis, inflammatory arthritis or fractures

Be receiving any other treatment for TMD or consuming some type of substance that alters muscle tone.

Patients with myopathies, diseases of the Peripheral Nervous System, mental disorders diagnosed by a doctor

Trial design

Design model

Parallel

Treatments tested in this trial

  • Therapeutic Exercise

    Behavioral

    A therapeutic exercise program will be carried out

  • Pain Neurophysiology Education

    Behavioral

    A PNE program will be carried out

Treatment groups

36 Participants
are divided into 2 treatment groups
Group A: TE+PNE groupExperimental treatment 2 interventions
Group B: TE groupOther 1 intervention

Trial outcomes

Primary outcomes

1

Pain intensity

The intensity of pain will be evaluated using the Visual Analogue Scale that is represented by a 10cm line where the left end indicates "no pain" and the right end indicates "maximum pain".

Time frame
The scale will be passed at baseline, immediately after treatment, at 4 and 12 weeks and one year after treatment.

Secondary outcomes

1

Mouth opening without pain

The distance between the upper and lower mandibular central incisors will be measured using a TheraBite range of motion scale.

Time frame
at baseline, immediately after treatment, 4 and 12 weeks after treatment.
2

Orofacial disability and pain

The CF-PDI is a self-administered questionnaire that measures pain and disability outcomes related to craniofacial pain. It consists of 21 items, with a score ranging from 0 to 63 points. A higher score reflects higher levels of disability.

Time frame
at baseline, immediately after treatment, 4 and 12 weeks after treatment.
3

Catastrophism

The PCS consists of a self-administered questionnaire with 13 items for the evaluation of catastrophic thoughts. It is divided into three domains: helplessness, magnification and rumination. Higher values denote greater pain catastrophizing

Time frame
at baseline, immediately after treatment, 4 and 12 weeks after treatment.
4

Kinesiophobia

The Spanish version of the TSK-11 will be used to evaluate the fear of re-injury due to movement. This questionnaire has a structure of 11 items and 2 factors that includes avoidance and harm of activities. Higher scores reflect greater fear of movement

Time frame
at baseline, immediately after treatment, 4 and 12 weeks after treatment.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: